The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Spine Surgery Biologics Market Research Report 2024
Synopsis
Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.
Global Spine Surgery Biologics market is projected to reach US$ 3012.5 million in 2029, increasing from US$ 2141 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spine Surgery Biologics market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Spine Surgery Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Open Surgery
Minimally Invasive Surgery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Spine Surgery Biologics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.
Global Spine Surgery Biologics market is projected to reach US$ 3012.5 million in 2029, increasing from US$ 2141 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Spine Surgery Biologics market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Spine Surgery Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Segment by Application
Open Surgery
Minimally Invasive Surgery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Spine Surgery Biologics report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spine Surgery Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Spine Surgery Biologics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Open Surgery
1.3.3 Minimally Invasive Surgery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spine Surgery Biologics Market Perspective (2018-2029)
2.2 Spine Surgery Biologics Growth Trends by Region
2.2.1 Global Spine Surgery Biologics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Spine Surgery Biologics Historic Market Size by Region (2018-2023)
2.2.3 Spine Surgery Biologics Forecasted Market Size by Region (2024-2029)
2.3 Spine Surgery Biologics Market Dynamics
2.3.1 Spine Surgery Biologics Industry Trends
2.3.2 Spine Surgery Biologics Market Drivers
2.3.3 Spine Surgery Biologics Market Challenges
2.3.4 Spine Surgery Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spine Surgery Biologics Players by Revenue
3.1.1 Global Top Spine Surgery Biologics Players by Revenue (2018-2023)
3.1.2 Global Spine Surgery Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Spine Surgery Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spine Surgery Biologics Revenue
3.4 Global Spine Surgery Biologics Market Concentration Ratio
3.4.1 Global Spine Surgery Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spine Surgery Biologics Revenue in 2022
3.5 Spine Surgery Biologics Key Players Head office and Area Served
3.6 Key Players Spine Surgery Biologics Product Solution and Service
3.7 Date of Enter into Spine Surgery Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spine Surgery Biologics Breakdown Data by Type
4.1 Global Spine Surgery Biologics Historic Market Size by Type (2018-2023)
4.2 Global Spine Surgery Biologics Forecasted Market Size by Type (2024-2029)
5 Spine Surgery Biologics Breakdown Data by Application
5.1 Global Spine Surgery Biologics Historic Market Size by Application (2018-2023)
5.2 Global Spine Surgery Biologics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Spine Surgery Biologics Market Size (2018-2029)
6.2 North America Spine Surgery Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Spine Surgery Biologics Market Size by Country (2018-2023)
6.4 North America Spine Surgery Biologics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spine Surgery Biologics Market Size (2018-2029)
7.2 Europe Spine Surgery Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Spine Surgery Biologics Market Size by Country (2018-2023)
7.4 Europe Spine Surgery Biologics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spine Surgery Biologics Market Size (2018-2029)
8.2 Asia-Pacific Spine Surgery Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Spine Surgery Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Spine Surgery Biologics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spine Surgery Biologics Market Size (2018-2029)
9.2 Latin America Spine Surgery Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Spine Surgery Biologics Market Size by Country (2018-2023)
9.4 Latin America Spine Surgery Biologics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spine Surgery Biologics Market Size (2018-2029)
10.2 Middle East & Africa Spine Surgery Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Spine Surgery Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Spine Surgery Biologics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Spine Surgery Biologics Introduction
11.1.4 Medtronic Revenue in Spine Surgery Biologics Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 J & J
11.2.1 J & J Company Detail
11.2.2 J & J Business Overview
11.2.3 J & J Spine Surgery Biologics Introduction
11.2.4 J & J Revenue in Spine Surgery Biologics Business (2018-2023)
11.2.5 J & J Recent Development
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Detail
11.3.2 Stryker Corporation Business Overview
11.3.3 Stryker Corporation Spine Surgery Biologics Introduction
11.3.4 Stryker Corporation Revenue in Spine Surgery Biologics Business (2018-2023)
11.3.5 Stryker Corporation Recent Development
11.4 Nuvasive
11.4.1 Nuvasive Company Detail
11.4.2 Nuvasive Business Overview
11.4.3 Nuvasive Spine Surgery Biologics Introduction
11.4.4 Nuvasive Revenue in Spine Surgery Biologics Business (2018-2023)
11.4.5 Nuvasive Recent Development
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Detail
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Spine Surgery Biologics Introduction
11.5.4 Zimmer Biomet Revenue in Spine Surgery Biologics Business (2018-2023)
11.5.5 Zimmer Biomet Recent Development
11.6 Orthofix International
11.6.1 Orthofix International Company Detail
11.6.2 Orthofix International Business Overview
11.6.3 Orthofix International Spine Surgery Biologics Introduction
11.6.4 Orthofix International Revenue in Spine Surgery Biologics Business (2018-2023)
11.6.5 Orthofix International Recent Development
11.7 Globus Medical
11.7.1 Globus Medical Company Detail
11.7.2 Globus Medical Business Overview
11.7.3 Globus Medical Spine Surgery Biologics Introduction
11.7.4 Globus Medical Revenue in Spine Surgery Biologics Business (2018-2023)
11.7.5 Globus Medical Recent Development
11.8 alphatec spine
11.8.1 alphatec spine Company Detail
11.8.2 alphatec spine Business Overview
11.8.3 alphatec spine Spine Surgery Biologics Introduction
11.8.4 alphatec spine Revenue in Spine Surgery Biologics Business (2018-2023)
11.8.5 alphatec spine Recent Development
11.9 K2M
11.9.1 K2M Company Detail
11.9.2 K2M Business Overview
11.9.3 K2M Spine Surgery Biologics Introduction
11.9.4 K2M Revenue in Spine Surgery Biologics Business (2018-2023)
11.9.5 K2M Recent Development
11.10 Exactech
11.10.1 Exactech Company Detail
11.10.2 Exactech Business Overview
11.10.3 Exactech Spine Surgery Biologics Introduction
11.10.4 Exactech Revenue in Spine Surgery Biologics Business (2018-2023)
11.10.5 Exactech Recent Development
11.11 Wright Medical Technology
11.11.1 Wright Medical Technology Company Detail
11.11.2 Wright Medical Technology Business Overview
11.11.3 Wright Medical Technology Spine Surgery Biologics Introduction
11.11.4 Wright Medical Technology Revenue in Spine Surgery Biologics Business (2018-2023)
11.11.5 Wright Medical Technology Recent Development
11.12 X-Spine
11.12.1 X-Spine Company Detail
11.12.2 X-Spine Business Overview
11.12.3 X-Spine Spine Surgery Biologics Introduction
11.12.4 X-Spine Revenue in Spine Surgery Biologics Business (2018-2023)
11.12.5 X-Spine Recent Development
11.13 Nutech
11.13.1 Nutech Company Detail
11.13.2 Nutech Business Overview
11.13.3 Nutech Spine Surgery Biologics Introduction
11.13.4 Nutech Revenue in Spine Surgery Biologics Business (2018-2023)
11.13.5 Nutech Recent Development
11.14 Arthrex
11.14.1 Arthrex Company Detail
11.14.2 Arthrex Business Overview
11.14.3 Arthrex Spine Surgery Biologics Introduction
11.14.4 Arthrex Revenue in Spine Surgery Biologics Business (2018-2023)
11.14.5 Arthrex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
